Notably, high CAPS expression was associated with favorable prognosis in UCEC (HR = 0.46,95% CI: 0.29-0.72, P < 0.001), but correlated with poor survival outcomes in lower-grade glioma (LGG) (HR = 2.39, 95% CI: 1.69-3.38, P < 0.001). The gene discussed is CAPS; the disease is central nervous system cancer.